◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Stillwater Critical Minerals Corp.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2025Mar 31, 2025 FY 2024Mar 31, 2024 FY 2023Mar 31, 2023 FY 2022Mar 31, 2022 FY 2021Mar 31, 2021
Total Revenue 0.00 0.00 0.00 0.00 --
Operating Revenue 0.00 0.00 0.00 0.00 --
Selling General And Administration 1.8M 1.8M 2.3M 1.5M --
General And Administrative Expense 1.8M 1.8M 2.3M 1.5M --
Research And Development 390,348 404,387 446,978 544,084 --
Other Operating Expenses 1.8M 3.4M 1.7M 5.3M --
Operating Expense 4.1M 5.6M 4.5M 7.3M --
Operating Income -4.1M -5.6M -4.5M -7.3M --
EBIT -4.1M -5.6M -4.5M -7.3M --
Interest Income 26,559 30,624 9,858 9,829 --
Interest Income Non Operating 26,559 30,624 9,858 9,829 --
Net Interest Income 26,559 30,624 9,858 9,829 --
Other Income Expense 245,719 72,067 171,060 44,910 --
Other Non Operating Income Expenses 3,480 -- -- 44,910 96,891
Special Income Charges 348,245 488,106 375,560 0.00 --
Gain On Sale Of Security -106,006 -416,039 -204,500 -- --
Pretax Income -3.8M -5.5M -4.3M -7.3M --
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -3.8M -5.5M -4.3M -7.3M --
Net Income From Continuing Operation Net Minority Interest -3.8M -5.5M -4.3M -7.3M --
Net Income Including Noncontrolling Interests -3.8M -5.5M -4.3M -7.3M --
Net Income Common Stockholders -3.8M -5.5M -4.3M -7.3M --
Net Income -3.8M -5.5M -4.3M -7.3M --
EBITDA -4.1M -5.6M -4.5M -7.3M --
Normalized EBITDA -4.3M -5.7M -4.7M -7.3M --
Basic EPS -0.02 -0.03 -0.02 -0.04 --
Diluted EPS -0.02 -0.03 -0.02 -0.04 --
Basic Average Shares 225.2M 192.9M 174.4M 162.0M --
Diluted Average Shares 225.2M 192.9M 174.4M 162.0M --
Total Unusual Items 242,239 72,067 171,060 0.00 --
Total Unusual Items Excluding Goodwill 242,239 72,067 171,060 0.00 --
Tax Rate For Calcs 0.00 0.00 0.00 0.00 --
Normalized Income -4.0M -5.6M -4.5M -7.3M --
Diluted NI Availto Com Stockholders -3.8M -5.5M -4.3M -7.3M --
Gain On Sale Of Ppe 348,245 488,106 375,560 0.00 --
Net Income Continuous Operations -3.8M -5.5M -4.3M -7.3M --
Net Non Operating Interest Income Expense 26,559 30,624 9,858 9,829 --
Other Gand A 1.5M 1.2M 1.4M 825,985 --
Salaries And Wages 358,374 590,905 896,481 641,020 --
Total Expenses 4.1M 5.6M 4.5M 7.3M --
Line Item FY 2025Mar 31, 2025 FY 2024Mar 31, 2024 FY 2023Mar 31, 2023 FY 2022Mar 31, 2022 FY 2021Mar 31, 2021
Cash And Cash Equivalents 239,467 149,404 27,387 2.4M --
Cash Cash Equivalents And Short Term Investments 943,773 611,471 417,387 2.4M --
Cash Financial 239,467 149,404 27,387 2.4M --
Other Short Term Investments 704,306 462,067 390,000 0.00 --
Accounts Receivable 91,549 18,826 50,406 73,430 --
Receivables 841,087 604,693 824,150 687,034 --
Prepaid Assets 141,508 122,884 211,148 215,787 --
Current Assets 1.9M 1.3M 1.5M 3.3M --
Net PPE 3.6M 3.3M 3.0M 3.2M --
Total Non Current Assets 3.9M 3.6M 3.3M 3.4M --
Total Assets 5.8M 4.9M 4.8M 6.7M --
Accounts Payable 286,260 493,865 260,437 311,805 --
Payables 449,049 735,768 466,905 417,294 --
Payables And Accrued Expenses 449,049 735,768 466,905 417,294 --
Other Current Liabilities 177,103 -- -- -- 44,910
Current Liabilities 626,152 735,768 466,905 417,294 --
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 0.00 --
Total Liabilities Net Minority Interest 626,152 735,768 466,905 417,294 --
Common Stock 43.8M 39.2M 34.9M 33.3M --
Capital Stock 43.8M 39.2M 34.9M 33.3M --
Retained Earnings -42.1M -38.7M -33.4M -29.2M --
Common Stock Equity 5.2M 4.2M 4.3M 6.3M --
Stockholders Equity 5.2M 4.2M 4.3M 6.3M --
Total Equity Gross Minority Interest 5.2M 4.2M 4.3M 6.3M --
Total Capitalization 5.2M 4.2M 4.3M 6.3M --
Net Tangible Assets 5.2M 4.2M 4.3M 6.3M --
Tangible Book Value 5.2M 4.2M 4.3M 6.3M --
Working Capital 1.3M 603,280 985,780 2.9M --
Invested Capital 5.2M 4.2M 4.3M 6.3M --
Share Issued 232.9M 197.8M 177.4M 169.6M --
Ordinary Shares Number 232.9M 197.8M 177.4M 169.6M --
Duefrom Related Parties Current 749,538 585,867 773,744 613,604 --
Dueto Related Parties Current 162,789 241,903 206,468 105,489 --
Non Current Prepaid Assets 314,253 307,135 262,153 248,342 --
Other Equity Interest 3.5M 3.8M 2.8M 2.2M --
Treasury Shares Number -- 0.00 -- -- --
Line Item FY 2025Mar 31, 2025 FY 2024Mar 31, 2024 FY 2023Mar 31, 2023 FY 2022Mar 31, 2022 FY 2021Mar 31, 2021
Operating Cash Flow -4.2M -4.5M -3.5M -6.6M --
Cash Flow From Continuing Operating Activities -4.2M -4.5M -3.5M -6.6M --
Stock Based Compensation 358,374 590,905 896,481 641,020 --
Change In Working Capital -541,737 531,602 -96,677 45,601 --
Changes In Account Receivables -72,723 31,580 23,024 3,465 --
Change In Receivables -72,723 31,580 23,024 3,465 --
Change In Payables And Accrued Expense -207,605 233,428 -51,368 189,962 --
Change In Other Working Capital -242,785 223,312 -59,161 107,984 --
Other Non Cash Items -3,480 -- -- -44,910 -96,891
Capital Expenditure -285,960 -246,104 -230,661 -229,838 --
Purchase Of PPE -285,960 -246,104 -230,661 -229,838 --
Net PPE Purchase And Sale -285,960 -246,104 -230,661 -209,838 --
Investing Cash Flow -293,078 -246,104 -230,661 -209,838 --
Cash Flow From Continuing Investing Activities -293,078 -246,104 -230,661 -209,838 --
Issuance Of Capital Stock 4.8M 4.9M 0.00 5.9M --
Net Common Stock Issuance 4.8M 4.9M 0.00 5.9M --
Financing Cash Flow 4.6M 4.8M 1.4M 6.7M --
Cash Flow From Continuing Financing Activities 4.6M 4.8M 1.4M 6.7M --
Changes In Cash 90,063 122,017 -2.4M -107,439 --
Beginning Cash Position 149,404 27,387 2.4M 2.5M --
End Cash Position 239,467 149,404 27,387 2.4M --
Free Cash Flow -4.5M -4.7M -3.8M -6.8M --
Change In Prepaid Assets -18,624 43,282 -9,172 -255,810 --
Common Stock Issuance 4.8M 4.9M 0.00 5.9M --
Gain Loss On Sale Of PPE -348,245 -488,106 -225,560 0.00 --
Net Income From Continuing Operations -3.8M -5.5M -4.3M -7.3M --
Net Other Financing Charges -203,937 -92,730 -- -492,594 -104,679
Net Other Investing Changes -7,118 -- -- -- --
Operating Gains Losses -348,245 -488,106 -225,560 -- --
Proceeds From Stock Option Exercised 37,500 0.00 1.4M 1.3M --
Sale Of PPE -- -- 0.00 20,000 0.00
Unrealized Gain Loss On Investment Securities 106,006 416,039 204,500 0.00 --
NEWS
Loading news...
TRENDING
Loading...